AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get zenagamtide (the treatment being tested) or placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

NCT Number	NCT07668401
Lead Sponsor	Novo Nordisk A/S
Conditions	Obesity, Overweight
Enrollment	400 participants
Start Date	2027-01-07
Primary Completion	2029-01-11 (estimated)
Study Completion	2029-01-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-25